Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle
Benno Lickefett, Lulu Chu, Valentin Ortiz-Maldonado, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Advancements and challenges in CAR T cell therapy in autoimmune diseases
Georg Schett, Fabian Müller, Jule Taubmann, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 9, pp. 531-544
Closed Access | Times Cited: 28
Direct in vivo CAR T cell engineering
Lauralie Short, Robert A. Holt, Pieter R. Cullis, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 5, pp. 406-418
Open Access | Times Cited: 14
Basic Concepts and Indications of CAR T Cells
J. Berg, Heinz Läubli, Nina Khanna, et al.
Hämostaseologie (2025) Vol. 45, Iss. 01, pp. 014-023
Closed Access | Times Cited: 1
The complexity of immune evasion mechanisms throughout the metastatic cascade
Nicole M. Haynes, Thomas B Chadwick, Belinda S. Parker
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1793-1808
Closed Access | Times Cited: 8
Allogeneic “Off-the-Shelf” CAR T Cells: Challenges and Advances
Sophia Chen, Marcel R.M. van den Brink
Best Practice & Research Clinical Haematology (2024) Vol. 37, Iss. 3, pp. 101566-101566
Closed Access | Times Cited: 6
Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma
Sophia Stock, Veit Bücklein, Viktoria Blumenberg, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access
CD19-directed chimeric antigen receptor T-cell therapy: what can we learn from the haematologist?
Maria T. Kuipers, Maria T. Kuipers
Lupus Science & Medicine (2025) Vol. 12, Iss. 1, pp. e001157-e001157
Open Access
Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma
Binod Dhakal, Parameswaran Hari, Saurabh Chhabra, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010649-e010649
Open Access
Mechanistic Evaluation of Anti‐CD19 CAR‐T Cell Therapy Repurposed in Systemic Lupus Erythematosus Using a Quantitative Systems Pharmacology Model
Hyunseo Park, Ganesh M. Mugundu, Aman P. Singh
Clinical and Translational Science (2025) Vol. 18, Iss. 2
Open Access
Synthetic Receptor-Based Cell Therapies for Autoimmune Diseases: An Update
Mieszko Lachota, Radosław Zagożdżon
Cytotherapy (2025)
Open Access
CARs for Lymphoma
Ishan J Tatake, Jon Arnason
Best Practice & Research Clinical Haematology (2025), pp. 101601-101601
Closed Access
Implementation of chimeric antigen receptor (CAR) T-cell therapy in the NHS: prospects, promises and pitfalls
Ruff Joseph Macale Cajanding
British Journal of Nursing (2025) Vol. 34, Iss. 5, pp. S20-S30
Closed Access
Tumor-Infiltrating Lymphocyte Therapy for Melanoma and Other Solid Tumors: Looking Back, Yet Moving Forward
Alexander N. Shoushtari, Daniel J. Powell
Transplantation and Cellular Therapy (2025) Vol. 31, Iss. 3, pp. S581-S590
Open Access
ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights
Alaa M. Ali, John F. DiPersio
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy
Alfredo Sebastian Colina, Viren Shah, Ravi K. Shah, et al.
Frontiers in Molecular Medicine (2024) Vol. 4
Open Access | Times Cited: 3
Strategies for Improving CAR T Cell Persistence in Solid Tumors
Megen C Wittling, Anna C Cole, Brianna Brammer, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2858-2858
Open Access | Times Cited: 3
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells
Megen C Wittling, Hannah M. Knochelmann, Megan M Wyatt, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e008715-e008715
Open Access | Times Cited: 2
Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin’s lymphoma
David Frame, Marcus Geer, Salena Kasha, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
The Role of Chimeric Antigen Receptor T‐Cell Therapy in Immune‐Mediated Neurological Diseases
Gavin Brittain, Elisa Roldán, Tobias Alexander, et al.
Annals of Neurology (2024) Vol. 96, Iss. 3, pp. 441-452
Open Access | Times Cited: 1
Systemic toxicity of CAR-T therapy and potential monitoring indicators for toxicity prevention
Jingxian Li, Huiguang Chen, Chaoping Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Innovative cell therapies for systemic sclerosis: available evidence and new perspectives
Alain Lescoat, Monalisa Ghosh, Stephan Kadauke, et al.
Expert Review of Clinical Immunology (2024), pp. 1-15
Closed Access | Times Cited: 1
Barriers to CAR T-cell therapy in rheumatology
Karolina Lungova, Michael Putman
The Lancet Rheumatology (2024)
Closed Access | Times Cited: 1
Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: where do we stand today?
Xiang Zhou, K. Martin Kortuem, Leo Rasche, et al.
La Presse Médicale (2024), pp. 104265-104265
Open Access | Times Cited: 1
Programmable cancer treatments: Engineering biology approaches for living cures
Marc Biarnes-Carrera, Alexandra Sevko, Nicholas Glanville, et al.
Engineering Biology (2024) Vol. 8, Iss. 2-3, pp. 31-40
Open Access
L’ingénierie cellulaire au service de l’optimisation des CAR-T cells
Angélique Galatioto, Maxime Fredon, Jeanne Galaine
Bulletin de l Académie Nationale de Médecine (2024) Vol. 208, Iss. 8, pp. 1019-1029
Closed Access
Page 1 - Next Page

Scroll to top